Rhumbline Advisers grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 179,759 shares of the company’s stock after acquiring an additional 1,924 shares during the period. […]
313,381 Shares in BridgeBio Pharma, Inc (NASDAQ:BBIO) Purchased by Boone Capital Management LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Boone Capital Management LLC Makes New $8 26 Million Investment in BridgeBio Pharma, Inc (NASDAQ:BBIO) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
- Submitted New Drug Application to US Food and Drug Administration for acoramidis for the treatment of transthyretin amyloid cardiomyopathy based on positive results of Phase 3 ATTRibute-CM trial,.
BridgeBio Pharma Inc (BBIO) Misses Q4 EPS by 9c streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.